Impact of weight reduction on insulin resistance, adhesive molecules and adipokines dysregulation among obese type 2 diabetic patients by Abd El-Kader, Shehab M & Al-Jiffri, Osama H
Impact of  weight reduction on insulin resistance, adhesive molecules and adipokines 
dysregulation among obese type 2 diabetic patients
 
Shehab M Abd El-Kader1,  Osama H Al-Jiffri2
1. Departmentof  Physical Therapy, Faculty of  Applied Medical Sciences, King Abdulaziz University, Jeddah, 
    Saudi Arabia.
2. Department of  Medical Laboratory Technology, Faculty of  Applied Medical Sciences, King Abdulaziz 
    University, Jeddah, Saudi Arabia.
 
Abstract
Background: Type 2 diabetes mellitus is usually related to vascular problems and is associated with impairment in endothelial 
function characterized by impaired endothelial-dependent vasodilation and increased platelet adhesion. There is limitation in 
clinical studies that have addressed the beneficial effects of  weight reduction in modulating biomarkers of  endothelial dysfunc-
tion and adipokines dysregulation for obesity associated with type 2 diabetes mellitus. 
Objective: This study was designed to detect the effects of  weight loss on insulin resistance, adhesive molecules and adipokines 
dysregulation in obese type 2 diabetic patients. 
Methods: Eighty obese patients with type 2 diabetes mellitus, their age ranged from 35-55 years and their body mass index 
ranged from 31-37 kg/m2  were equally assigned into 2 groups:  the weight reduction group received aerobic exercises in addition 
to diet regimen, where the control group received medical treatment only for 12 weeks. 
Results: There was a 24.04%, 19.33%, 22.78% ,12.28%, 9.35%, 22.53% & 10.12 % reduction in mean values of  Homeostasis 
Model Assessment-Insulin Resistance Index (HOMA-IR), Leptin, Adiponectin, Resistin, intercellular cell adhesion molecule 
-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin & body mass index (BMI) respectively in addition 
to 26.20% & 24.58% increase in the mean values of  adiponectin & the quantitative insulin-sensitivity check index (QUICKI) 
respectively in group (A) at the end of  the study. The mean values of  leptin, resistin, insulin, HOMA-IR, ICAM-1, VCAM-1, 
E-selectin & BMI were significantly decreased in addition to significant increase in the mean values of  adiponectin & QUICKI 
in group (A) those that received aerobic exercise training in addition to diet regimen. While the results of  group (B) those that 
received no treatment intervention were not significant. In addition, there were significant differences between mean levels of  
the investigated parameters in group (A) and group (B) after treatment (P<0.05).
Conclusion: Within the limit of  this study, 10% reduction in body mass index modulates insulin resistance, adhesive molecules 
and adipokines dysregulation among obese type 2 diabetic patients.
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Introduction
Type 2 diabetes (T2DM) is an important cardiovascular 
(CV) risk factor1. Obesity represents a state of  increase in 
adipose tissue mass due to the increase in the number and 
size of  adipocytes2. Diabetes increases cardiovascular risk 
and reduces life expectancy, with most of  excess mortality 
being attributable to cardiovascular causes3. In addition, 
T2DM is typically associated with reduced   high density 
lipoprotein cholesterol (HDL-C) and impaired HDL-C 
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function4,5. The hypertension that typically accompanies 
T2DM seems to be the most significant contributor to 
this increased risk6.  
 
Adipose tissue is recognized as an active endocrine or-
gan, which secretes adipocytokines involved in the local 
and systemic regulation of  numerous metabolic and in-
flammatory processes7. Dysregulated endocrine function 
of  the adipose tissue contributes to the development of  
obesity related metabolic disorders including insulin re-
sistance, T2DM and atherosclerosis8.
 
Adiponectin is an adipokine with insulin sensitizing and 
anti-inflammatory activities. Adiponectin and insulin re-
sistance is an important link between visceral adiposity 
and atherosclerosis. Adiponectin improves systemic glu-
cose tolerance and protects the vasculature from ath-
erosclerosis9. Adiponectin exerts both vasodilatory and 
insulin-sensitizing actions and its levels are decreased in 
insulin-resistant humans and animals10. Circulating levels 
of  adiponectin decrease both in obesity and in patients 
with T2DM. There is a close association between in-
flammatory markers, insulin resistance and incidence of  
T2DM11.  Additionally, hypoadiponectinemia is an inde-
pendent risk factor for developing T2DM and cardiovas-
cular disease12.  
 
Type 2 diabetic patients have abnormal levels of  inflam-
matory markers, which lead to endothelial cell dysfunc-
tion13, which may be induced by hyperlipidemia, hyper-
insulinemia and pancreatic β-cell failure14. Insulin has 
an essential role in regulation of  vascular function by 
stimulation of  the expression of  vascular cell adhesion 
molecule (vascular cell adhesion molecule-1 (VCAM-
1), intercellular cell adhesion molecule -1 (ICAM-1) and 
E-selectin on endothelium, that is why endothelial dys-
function is associated with insulin resistance15. Endothe-
lial dysfunction is characterized by prothrombic proper-
ties,pro-inflammatory state and reduced vasodilation16,17. 
Endothelial function is a marker of  overall cardiovascular 
health and a predictor of  future cardiovascular events18.
Aerobic exercises associated with appropriate diet reg-
imen were reported to protect against atherosclerosis 
in non-insulin dependent diabetes mellitus19. However, 
weight reduction program modulates markers of  system-
ic inflammation, endothelial function and adipokines that 
are usually associated with better cardiovascular system 
prognosis in obese subjects20,21.
As there is inconclusive data regarding the impact of  
weight reduction upon the adipokines and adhesive mol-
ecules dysregulation in obese type 2 diabetic patients, 
therefore, the study aimed to determine the impact of  12 
weeks of  weight reduction program on insulin resistance, 
adipokines and adhesive molecules dysregulation in obese 




Eighty obese T2DM patients (48 males and 32 females) 
with body mass index (BMI) ranged from 30 to 34 Kg/
m2, treated with oral hypoglycemic agents e.g. metformin 
and/or pioglitazone were selected for the study on re-
ferral to Internal Medicine Department, King Abdulaziz 
University Teaching Hospital, Saudi Arabia. They were 
checked for fasting/random glucose levels. Only par-
ticipants who had fasting blood sugar levels more than 
5.6 mmol/l or random blood sugar level more than 7.8 
mmol/l (impaired blood sugar) were included in this study 
and  were further checked for type 2 diabetes mellitus 
as per recent American Diabetes Association criteria i.e. 
fasting blood sugar ≥7.0 mmol/l or post-prandial blood 
sugar ≥11.1 mmol/l 2-h plasma glucose 11.1 mmol/l 
during an oral glucose tolerance test and glycosylated he-
moglobin (HbA1c%) > 6.5%22. Exclusion criteria includ-
ed smokers, kidney insufficiency, congestive heart failure, 
pregnant female patients, hepatitis and respiratory failure. 
Detailed clinical history was obtained and p included the 
age, sex, symptoms suggestive of  diabetes and family his-
tory of  diabetes. Physical examinations included anthro-
pometric measurements such as height, weight, BMI and 
waist circumference.
Participants were included two groups; group (A) re-
ceived treadmill aerobic exercise training on treadmill in 
addition to diet regimen. However, group (B) received no 
exercise training. The CONSORT diagram outlining the 
details of  the screening, run-in and randomization phases 
of  the study and reasons for participant exclusion can be 
found in figure (1). Informed consent was obtained from 
all participants. This study was approved by the Scientific 
Research Ethical Committee, Faculty of  Applied Medical 
Sciences at King Abdulaziz University. 
African Health Sciences Vol 18 Issue 4, December, 2018874
Measurements
All laboratory examinations were performed at Laborato-
ry of  King Abdalaziz University Teaching Hospitals.
A. Measurement of  adiopkines and insulin resistance:  After a 10 
hours overnight fast, venous blood samples were drawn 
to determine levels of  leptin, adiponectin and resistin. Se-
rum level of  leptin was measured with DRG leptin ELI-
SA Catalog number EIA-2395, supplied by DRG instru-
ments GmbH, Germany and serum level of  adiponectin 
was determined using AviBion human adiponectin (Acrp 
30) ELISA kit ref. no. ADIPO 25 (Orgenium Labora-
tories, Finland), while serum level of  resistin was mea-
sured by ELISA using commercially available kits (resistin 
Rapidbio, West Hills, CA, USA; CK-18: PEVIVA, Alexis, 
Grunwald, Germany) according to the manufacturer’s in-
structions. Human insulin was measured with an insulin 
kit (Roche Diagnostics, Indianapolis, IN, USA) using a 
cobas immunoassay analyzer(Roche Diagnostics). Insu-
lin resistance was assessed by homeostasis model assess-
ment (HOMA-IR). HOMA-IR = fasting blood glucose 
(mmol/l) _ fasting insulin (mIU/ml)/22.523. However, 
insulin sensitivity was assessed by The quantitative insu-
lin-sensitivity check index (QUICKI) using the formula: 
QUICKI=1/log(insulin) + log(glucose)24. All serum sam-
ples were analyzed in duplicates.
B. Measurement of  adhesive molecules biomarkers: Biomarkers 
of  adhesive molecules which included adhesion mole-
cules (ICAM-1 and VCAM-1) and soluble E-selectin lev-
els were measured from frozen plasma samples stored 
at −80 °C. Enzyme-linked immunosorbent assays kits 
(ELISAs) were used to measure soluble levels of  ICAM-
1, VCAM-1 and sE-selectin (GE Healthcare Amersham, 
Biotrak Easy ELISA), which employs the quantitative 
sandwich enzyme immunoassay technique.












Assessed for eligibility (n= 188 ) 
Excluded  (n=76) 
   Not meeting inclusion criteria (n=54) 
   Declined to participate (n=16) 
   Other reasons (n=6) 
Analysed  (n=40) 
Excluded from analysis (n=4) 
Moved away=1  Declined=3 
Lost to follow-up (n=5) 




Allocated to intervention (n=54) 
 Received allocated intervention (n=49) 
 Did not receive allocated intervention (n=5) 
Group assignment= 2    Time constraint= 3 
Lost to follow-up  (n=4) 
Time constrains=2   Other reason=2 
Allocated to intervention (n=58) 
 Received allocated intervention (n=47) 
 Did not receive allocated intervention (n=11) 
Failed to attend=4  Time constraint=7 
Analysed  (n=40) 
Excluded from analysis (n=3) 
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Table (1): Mean value of baseline characteristics of subjects for participants in both groups 
  
  Group (A) Group (B) Significance 
Age (year) 48.73 ± 6.26 50.12 ±  5.91 P>0.05 
Gender (male/female) 23/17 25/15 P>0.05 
BMI (kg/m2) 32.51 ± 3.87 33.14 ± 3.22 P>0.05 
Duration of diabetes(years) 12.23 ± 4.64 11.52 ± 4.58 P>0.05 
Waist circumference (cm) 103.42 ± 8.36 101.47 ± 7.93 P>0.05 
Waist-hip ratio 0.97 ± 0.08 0.93 ± 0.07 P>0.05 
Body fat (%) 
  
36.4 ± 7.61 
  
35.88 ± 6.95 
  P>0.05 
SBP (mmHg) 143.57 ± 10.31 145.41 ± 9.86 P>0.05 
DBP (mmHg) 87.44 ± 7.15 88.69 ± 8.21 P>0.05 
Total Cholesterol ( mg/dL) 199.72± 21.63 196.94 ± 19.54 P>0.05 
HDL-C( mg/dL) 43.81 ± 8.45 46.17 ± 9.38 P>0.05 
Triglycerides( mg/dL) 145.64 ± 13.87 142.33 ± 14.56 P>0.05 
HBA1c (%) 9.17 ± 2.53 8.92 ± 2.65 P>0.05 
Glucose (mmol/L) 
  
5.32 ± 1.13 
  
5.18 ± 1.08 
  P>0.05 
Insulin (pmol/L) 
  
21.49 ± 4.76 
  
19.98 ± 5.14 
  P>0.05 
BMI: Body Mass Index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure;  
HDL-C: High-density lipoprotein cholesterol; HBA1c: glycosylated hemoglobin. 
of  all participants was measured with (HC4211, Cas 
Korea, South Korea) while wearing hospital gowns and 
undergarments. Where the height was measured with a 
digital stadiometer (JENIX DS 102, Dongsang), so Body 
Mass Index (BMI) was computed as BMI= Body weight/
Height2.
Procedures
All participants were divided randomly into the following 
groups:
1. Group (A): Forty obese type 2 diabetic patients were 
submitted to the aerobic exercise training to complete 
a 12-week aerobic exercise on a treadmill which was 
conducted according to recommendation of  American 
College of  Sports Medicine  regarding aerobic exercise 
application25.Training program included 5 minutes for 
warming –up in the form of  range motion and stretching 
exercises, 30 minutes of  aerobic exercise training ( 60-
70% of  maximum heart rate) and 10 minutes of  cooling 
down ( on treadmill with low speed and without incli-
nation). Participants had 3 sessions /week for 3 months 
with close supervision of  physical therapist. In addition, 
a dietician performed an interview-based food survey 
for all participants of  group (A) for detection of  feeding 
habits, abnormal dietary behavior and to prescribe the 
balanced low caloric diet that provides 1200 Kilocalories/
day for 12 weeks.
2. Group (B):  Forty obese type 2 diabetic patients of  
both sexes maintained their ordinary life style and re-
ceived no exercise training.
 
Statistical analysis
The mean values of  the investigated parameters obtained 
before and after three months in both groups were com-
pared using paired "t" test. Independent "t" test was used 
for the comparison between the two groups (P<0.05).
 
Results
Eighty obese patients with type 2 diabetes mellitus com-
pleted the screening evaluation. The baseline character-
istics of  the participants are shown in table (1). Most 
participants (60%) were men. Forty participants were as-
signed group (A) (n = 40; 23 males and 16 females) and 
group (B) (n =40, 25 males and 15 females). None of  the 
baseline characteristics differed significantly between the 
two groups as listed in table (1).
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Table (2): Mean value and significance of BMI, QUICKI, HOMA-IR, Leptin,  
Adiponectin, Resistin, ICAM-1, VCAM-1 and E-selectin in group (A) before and  
after treatment. 
 
  Mean +SD T-value Significance Pre Post 
BMI (kg/m2) 32.51 ± 3.87* 29.22 ± 3.74   6.73      P<0.05 
QUICKI 0.118 ± 0.019* 0.147 ± 0.015   5.12 P <0.05 
HOMA-IR 5.24  ± 1.57* 3.98 ± 1.31    4.67 P <0.05 
Leptin(Ng/ml) 30.21 ± 4.32* 24.37 ± 3.91    6.32 P<0.05 
Adiponectin(μg/mL) 10.42 ± 2.65* 13.15 ± 2.48 5.74 P<0.05 
Resistin  (ng/mL) 15.23± 2.87* 11.76 ± 2.22     6.21 P <0.05 
ICAM-1(ng/ml) 92.71 ± 9.36* 81.32 ± 8.17 7.56 P<0.05 
VCAM-1 (ng /ml) 816.58 ± 28.15* 740.26 ± 21.83 9.81 P<0.05 
E-selectin(ng/ml) 15.93 ± 2.76* 12.34 ± 2.54 7.56 P<0.05 
BMI: Body Mass Index; QUICKI: The quantitative insulin-sensitivity check index; HOMA-IR:  
Homeostasis Model Assessment-Insulin Resistance Index; ICAM-1: Inter-Cellular Adhesion Molecule;  
VCAM-1: Vascular Cell Adhesion Molecule; (*) indicates a significant difference, P < 0.05. 
  
Table (3): Mean value and significance of BMI, QUICKI, HOMA-IR, Leptin,  
Adiponectin, Resistin, ICAM-1, VCAM-1 and E-selectin in group (B) before and  
after treatment. 
 
  Mean +SD T-value Significance Pre Post 
BMI (kg/m2) 33.14 ± 3.22 33.85 ± 3.23    1.19 P>0.05 
QUICKI 0.121 ± 0.024 0.115 ± 0.018     0.87 P > 0.05 
HOMA-IR 5.63 ± 2.13 5.97 ± 2.24     1.26 P > 0.05 
Leptin(Ng/ml) 31.36 ± 4.16 31.68 ± 4.51 1.40 P>0.05 
Adiponectin(μg/mL) 10.15 ± 2.32 9.87 ± 2.17 0.86 P <0.05 
Resistin  (ng/mL) 16.11 ± 2.53 16.34 ± 2.18     1.21 P > 0.05 
ICAM-1(ng/ml) 93.19 ± 10.22 94.50 ± 9.83 1.58 P>0.05 
VCAM-1 (ng /ml) 820.21 ± 26.75 826.10± 29.21 1.89 P>0.05 
E-selectin(ng/ml) 16.14 ± 2.50 16.62 ± 2.65 0.84 P>0.05 
BMI: Body Mass Index; QUICKI: The quantitative insulin-sensitivity check index; HOMA-IR:  
Homeostasis Model Assessment-Insulin Resistance Index; ICAM-1: Inter-Cellular Adhesion Molecule;  
VCAM-1: Vascular Cell Adhesion Molecule. 
There was a 24.04%, 19.33%, 22.78% ,12.28%, 9.35%, 
22.53% & 10.12 % reduction in mean values of  HO-
MA-IR, Leptin, Adiponectin, Resistin, ICAM-1, VCAM-
1 and E-selectin & BMI respectively in addition to 26.20% 
& 24.58%  increase in the mean values of  adiponectin & 
QUICKI  respectively in group (A) at the end of  the study. 
The mean values of  leptin, resistin, insulin, HOMA-IR, 
ICAM-1, VCAM-1, E-selectin & BMI were significantly 
decreased in addition to significant increase in the mean 
values of  adiponectin & QUICKI in group (A) those that 
received aerobic exercise training in addition to diet reg-
imen. While the results of  group (B) who received no 
treatment intervention were not significant. Also, there 
were significant differences between mean levels of  the 
investigated parameters in group (A) and group (B) after 
treatment (Table 2, 3, & 4) (P<0.05).
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Table (4): Mean value and significance of BMI, QUICKI, HOMA-IR, Leptin,  
Adiponectin, Resistin, ICAM-1, VCAM-1 and E-selectin in group (A) and group  
(B) at the end of the study. 
 
  Mean +SD T-value Significance Group (A) Group (B) 
BMI (kg/m2) 29.22 ± 3.74* 33.85 ± 3.23    5.23 P <0.05 
QUICKI 0.147 ± 0.015* 0.115 ± 0.018     4.10 P <0.05 
HOMA-IR 3.98± 1.31* 5.97 ± 2.24     3.83 P <0.05 
Leptin(Ng/ml) 24.37 ± 3.91* 31.68 ± 4.51     5.14 P <0.05 
Adiponectin(μg/mL) 13.15 ± 2.48* 9.87 ± 2.17 4.32 P <0.05 
Resistin  (ng/mL) 11.76 ± 2.22* 16.34 ± 2.18     5.12 P <0.05 
ICAM-1(ng/ml) 81.32 ± 8.17* 94.50 ± 9.83 6.43 P <0.05 
VCAM-1 (ng /ml) 740.26 ± 21.83* 826.10± 29.21 8.26 P <0.05 
E-selectin(ng/ml) 12.34 ± 2.54* 16.62 ± 2.65 6.27 P <0.05 
BMI: Body Mass Index; QUICKI : The quantitative insulin-sensitivity check index; HOMA-IR:  
Homeostasis Model Assessment-Insulin Resistance Index; ICAM-1: Inter-Cellular Adhesion Molecule;  
VCAM-1:Vascular Cell Adhesion Molecule; (*) indicates a significant difference, P < 0.05. 
Discussion
Type 2 diabetes mellitus is characterized by hyperglyce-
mia due to insulin resistance, which over time leads to a 
myriad of  micro- and macrovascular complications. Indi-
viduals with T2DM are at a much higher risk (two to four 
times that of  the background population) of  developing 
coronary artery disease26, peripheral vascular disease27, 
and cerebrovascular disease28. Mortality from cardiovas-
cular disease may be up to four times higher in patients 
with T2DM29. However, adiponectin is a circulating ad-
ipose tissue-derived hormone that is down regulated in 
obese individuals30. Experimental studies show that ad-
iponectin plays a protective role in the development of  
insulin resistance, atherosclerosis, and inflammation31. 
Insulin resistance and its manifestations predict and pre-
cede T2DM and its cardiovascular complications32. Insu-
lin resistance characterizing obese subjects has also been 
shown to be associated with endothelial dysfunction33,34. 
The optimal management of  obesity starts with a combi-
nation of  diet, physical activity, and behavioral modifica-
tion. Previous studies demonstrated beneficial effects of  
exercise training and caloric restrictions on pro-inflam-
matory state associated with endothelial dysfunction after 
weight loss35-37.
The main finding of  the present study was that weight 
reducing program ameliorate insulin resistance, adhesive 
molecules (ICAM-1 VCAM-1 and E-selectin) as well as 
improvement in adipokines dysregulation (Adiponectin, 
Leptin and Resistin) in obese type 2 diabetic patients as a 
result of  weight loss, these results are in line with many 
previous studies.
Regarding insulin resistance, this study proved that life 
style modification (aerobic exercise and diet regimen) sig-
nificantly improved insulin resistance because of  weight 
reduction. These results agreed with Angelico et al. who 
proved that 5%-10% weight loss as a result of  diet reg-
imen modulates insulin resistance in patients with meta-
bolic syndrome38, also Bacchi et al. conducted a random-
ized controlled trial of  31 sedentary adults with type 2 
diabetes and non-alcoholic fatty liver comparing the ef-
fects of  4 months of  aerobic and resistance training on 
insulin sensitivity and hepatic steatosis. Hepatic fat con-
tent, hepatic steatosis and insulin sensitivity were reduced 
in both intervention groups39. Several mechanisms have 
been proposed to be responsible for the increases in in-
sulin sensitivity after exercise training. These include in-
creased post-receptor insulin signaling, increased glucose 
transporter protein and mRNA, increased activity of  gly-
cogen syntheses and hexokinase, decreased release and 
increased clearance of  free fatty acids, increased muscle 
glucose delivery and changes in muscle composition40.
Concerning adhesive molecules, this study proved that 
life style modification (aerobic exercise and diet reg-
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imen) significantly improved ICAM-1, VCAM-1 and 
E-selectin because of  weight reduction. These results 
agreed with previous studies conducted in obese pop-
ulations that have shown reductions in VCAM-141 and 
ICAM-142-44 following weight loss. Sharman and Volek 
conducted a 6-week crossover dietary intervention with 
reduced energy diets (low fat vs very low carbohydrate 
~1500 kcal) in 15 overweight men, resulted in reduction 
in plasma ICAM-145. Forsythe et al. conducted a parallel 
study with longer period dietary intervention (12-week) 
in a group of  overweight individuals with dyslipidemia 
and stated that  weight reduction was achieved which led 
to reduction in E-selectin and ICAM46. Thomson et al. 
conducted a study on 50 overweight/obese women with 
polycystic ovary syndrome to determine if  20 weeks of  
a high-protein energy-restricted diet with or without ex-
ercise in women with polycystic ovary syndrome could 
improve endothelial function. Participants were randomly 
assigned by computer generation to one of  three 20-week 
interventions: diet only (6000 kJ/day), diet and aerobic 
exercise (6000 kJ/day and 5 walking sessions/week) and 
diet and combined aerobic-resistance exercise (6000 kJ/
day, three walking and two-strength sessions/week). All 
three treatments resulted in significant weight loss, also 
VCAM-1 and ICAM-1 levels decreased with weight loss 
with no differences between treatments47. 
Garanty-Bogacka et al. applied a study on fifty six obese 
adolescents, participating in an obesity intervention pro-
gram, were studied before and after 1 year program con-
sisting of  moderate physical activity (exercise group in-
cluding 37 participants) or hypocaloric diet (diet group: 
19 subjects) and concluded that moderate-intensity train-
ing alone reduced cell adhesion (VCAM-1 and ICAM-1) 
in obese adolescents more than observed after caloric 
restriction48. The mechanisms of  adhesive molecules im-
provement are not clearly elucidated, but some studies 
suggest that reduction in circulating level of  markers of  
endothelial activation and oxidative stress49,50 as well as 
increases in nitrous oxide bioavailability through repeti-
tive increase of  shear stress may serve as mechanisms51,52.
Regarding adipokines levels, this study proved that life 
style modification (aerobic exercise and diet regimen) 
significantly modulated adipokines (Adiponectin, Leptin 
and Resistin) because of  weight reduction. These re-
sults agreed with Lang et al. investigated the effects of  
an 8-week weight-control program on serum adiponec-
tin and blood lipid level profiles in 3 obese men and 11 
obese women, their findings suggest that weight reduc-
tion has anti-inflammatory and anti-atherogenic effects 
via increased serum adiponectin levels53. Esposito et al. 
reported that lifestyle modification by obese subjects for 
a period of  2 years led to decreased body weight and C-re-
active protein but increased adiponectin levels54 as adi-
ponectin secretion may be inhibited by obesity through 
a feedback loop55. Rokling-Andersen et al. examined the 
separate and combined effects of  a  one year exercise and 
diet intervention on several adipokines and concluded 
that beyond the effects on body fatness, diet or exercise 
intervention alone or in combination mainly had effects 
on adiponectin and tumor necrosis factor- alpha (TNF-α) 
concentrations56. In addition, previous studies demon-
strated that long-term weight loss after bariatric surgery is 
accompanied by a decreased pro-inflammatory state and 
increased the circulating level of  adiponectin57-61. Jung et 
al. proved that long-term exercise program and a diet led 
obese individuals to reduce significantly the level of  re-
sistin and leptin62. Jones et al. have studied the effect of  
8-week aerobic exercise on lipid levels of  serum, leptin, 
adiponectin, and resistin in overweight adolescents and 
reported a significant decrease of  resistin63. Kadoglou et 
al. studied the effect of  16-week regular aerobic exercises 
with a maximal oxygen consumption (VO2max) of  50 to 
85 percent on resistin level in patients with type 2 diabetic 
and overweight ones. They reported a significant decrease 
in resistin level among the participants64. In the study by 
Elloumi et al. two months of  exercise with weight loss, 
led to a significant decrease in resistin level among obese 
adolescents65. Balducci et al. reported that 12 months of  
regular physical activity could decrease the level of  re-
sistin in patients with diabetes and obesity66.
 
The current study has important strengths and limitations. 
The major strength is the supervised nature of  the study. 
Supervising physical activity and diet regimen remove the 
need to question compliance or to rely on activity ques-
tionnaires. Further, all exercise sessions were supervised 
and adherence to the activities was essentially 100%. In 
addition, our study had a large number of  subjects en-
rolled/involved, leading to excellent statistical power to 
detect exercise exposure effects across groups. Moreover, 
the study was randomized; hence, we can extrapolate ad-
herence to the general population. On the other hand, 
the major limitations is that this study did not include 
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some biomarkers that could be modulated with weight 
reduction among patients with T2DM. Finally, within the 
limit of  this study, 10% reduction in body mass index 
modulates insulin resistance, adhesive molecules and ad-
ipokines dysregulation among obese type 2 diabetic pa-
tients. Further researches are needed to explore the im-
pact of  different exercise training techniques on quality 
of  life and other biochemical parameters among patients 
with type 2 diabetes mellitus.
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